BioCryst Pharmaceuticals, Inc. (BCRX)
7.53
-0.15
(-1.95%)
USD |
NASDAQ |
Nov 13, 11:01
BioCryst Pharmaceuticals Net Income (Annual) : 263.86M for Dec. 31, 2025
Net Income (Annual) Chart
Historical Net Income (Annual) Data
| Date | Value |
|---|---|
| December 31, 2025 | 263.86M |
| December 31, 2024 | -88.88M |
| December 31, 2023 | -226.54M |
| December 31, 2022 | -247.12M |
| December 31, 2021 | -184.06M |
| December 31, 2020 | -182.81M |
| December 31, 2019 | -108.90M |
| December 31, 2018 | -101.25M |
| December 31, 2017 | -65.78M |
| December 31, 2016 | -55.14M |
| December 31, 2015 | -43.02M |
| December 31, 2014 | -45.19M |
| December 31, 2013 | -30.11M |
| December 31, 2012 | -39.08M |
| December 31, 2011 | -56.95M |
| December 31, 2010 | -33.85M |
| Date | Value |
|---|---|
| December 31, 2009 | -13.45M |
| December 31, 2008 | -24.73M |
| December 31, 2007 | -29.06M |
| December 31, 2006 | -43.62M |
| December 31, 2005 | -26.10M |
| December 31, 2004 | -21.10M |
| December 31, 2003 | -12.70M |
| December 31, 2002 | -16.93M |
| December 31, 2001 | -4.986M |
| December 31, 2000 | -5.490M |
| December 31, 1999 | -5.298M |
| December 31, 1998 | -4.785M |
| December 31, 1997 | -10.62M |
| December 31, 1996 | -7.698M |
| December 31, 1995 | -8.576M |
| December 31, 1994 | -6.938M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Annual) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Annual) Benchmarks
| Amgen, Inc. | 7.711B |
| Halozyme Therapeutics, Inc. | 316.89M |
| Neurocrine Biosciences, Inc. | 478.60M |
| Agenus, Inc. | -3.083M |
| Anika Therapeutics, Inc. | -9.979M |